Type to search

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy | PTF
Vaxzevria Approved in the EU as Third Dose Booster Against COVID-19 | Pharmtech Focus
AstraZeneca Signs Licence Agreement With RQ Biotechnology for Monoclonal Antibodies Against COVID-19 | Pharmtech Focus